HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Olivier Verola Selected Research
Olivier Verola Research Topics
Disease
5
Neoplasms (Cancer)
09/2015 - 05/2003
2
Aggressive Fibromatosis (Desmoid)
09/2015 - 06/2010
2
Melanoma (Melanoma, Malignant)
10/2009 - 08/2009
1
Neoplasm Micrometastasis
10/2009
1
Cicatrix (Scar)
08/2008
1
Kaposi Sarcoma (Kaposi's Sarcoma)
04/2008
1
Acquired Immunodeficiency Syndrome (AIDS)
04/2008
1
Sarcoma (Soft Tissue Sarcoma)
03/2008
1
Coma (Comas)
03/2008
1
Zygomycosis (Phycomycosis)
12/2006
Drug/Important Bio-Agent (IBA)
2
Complementary DNA (cDNA)
IBA
09/2015 - 05/2003
1
beta Catenin
IBA
06/2010
1
DNA (Deoxyribonucleic Acid)
IBA
06/2010
1
Biomarkers (Surrogate Marker)
IBA
10/2009
1
Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))
IBA
10/2009
1
Monophenol Monooxygenase (Tyrosinase)
IBA
10/2009
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
10/2009
1
Antigens
IBA
10/2009
1
Differentiation Antigens
IBA
10/2009
1
MHC class II transactivator protein
IBA
08/2009
1
Histocompatibility Antigens Class II
IBA
08/2009
1
HLA-DR Antigens (HLA-DR)
IBA
08/2009
1
Phosphotransferases (Kinase)
IBA
08/2009
1
Chemokines
IBA
08/2009
1
Mitogen-Activated Protein Kinases
IBA
08/2009
1
Sulfides (Thioethers)
IBA
08/2008
1
Interferon-alpha (Interferon Alfa)
IBA
04/2008
1
Imiquimod (Aldara)
FDA Link
Generic
04/2008
1
Sunitinib (Sutent)
FDA Link
03/2008
1
Amphotericin B (Amphotericin)
FDA Link
Generic
12/2006
1
Messenger RNA (mRNA)
IBA
05/2003
Therapy/Procedure
1
Debridement
12/2006